NEFL and Alzheimer disease: In the recently revised diagnostic and staging criteria for AD, the indicators of N are mainly observed from anatomic magnetic resonance imaging (MRI), 18F‐fluorodeoxyglucose positron emission tomography (FDG PET) scans, and cerebrospinal fluid (CSF) or plasma‐based neurofilament light chain (NfL).4